344 related articles for article (PubMed ID: 28766840)
1. High birth prevalence of sickle cell disease in Northwestern Tanzania.
Ambrose EE; Makani J; Chami N; Masoza T; Kabyemera R; Peck RN; Kamugisha E; Manjurano A; Kayange N; Smart LR
Pediatr Blood Cancer; 2018 Jan; 65(1):. PubMed ID: 28766840
[TBL] [Abstract][Full Text] [Related]
2. Genetic Blood Disorders Survey in the Sultanate of Oman.
Al-Riyami A; Ebrahim GJ
J Trop Pediatr; 2003 Jul; 49 Suppl 1():i1-20. PubMed ID: 12934793
[TBL] [Abstract][Full Text] [Related]
3. Neonatal screening for sickle cell disease and other hemoglobinopathies in "the changing Europe".
Rolla R; Castagno M; Zaffaroni M; Grigollo B; Colombo S; Piccotti S; Dellora C; Bona G; Bellomo G
Clin Lab; 2014; 60(12):2089-93. PubMed ID: 25651745
[TBL] [Abstract][Full Text] [Related]
4. [Prevalence of abnormal hemoglobins in newborns in Natal, Rio Grande do Norte, Brazil].
de Araújo MC; Serafim ES; de Castro WA; de Medeiros TM
Cad Saude Publica; 2004; 20(1):123-8. PubMed ID: 15029312
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of high performance liquid chromatography (HPLC) pattern and prevalence of beta-thalassaemia trait among sickle cell disease patients in Lagos, Nigeria.
Adeyemo T; Ojewunmi O; Oyetunji A
Pan Afr Med J; 2014; 18():71. PubMed ID: 25400838
[TBL] [Abstract][Full Text] [Related]
6. Extremely high birth prevalence of sickle cell disease in rural Tanzania.
Eastburg L; Peckham A; Kawira E; Chirangi B; Adler D; Akungo BD; Smart LR; Ambrose EE
Pediatr Blood Cancer; 2020 Nov; 67(11):e28620. PubMed ID: 32803850
[TBL] [Abstract][Full Text] [Related]
7. Microcytic hypochromic anemia: should high performance liquid chromatography be used routinely for screening anemic and antenatal patients?
Philip J; Sarkar RS; Kushwaha N
Indian J Pathol Microbiol; 2013; 56(2):109-13. PubMed ID: 24056645
[TBL] [Abstract][Full Text] [Related]
8. [Prevalence of sickle cell trait and sickle cell anemia among newborns in the Federal District, Brazil, 2004 to 2006].
Diniz D; Guedes C; Barbosa L; Tauil PL; Magalhães I
Cad Saude Publica; 2009 Jan; 25(1):188-94. PubMed ID: 19180301
[TBL] [Abstract][Full Text] [Related]
9. Forecasting hemoglobinopathy burden through neonatal screening in Omani neonates.
Alkindi S; Al Zadjali S; Al Madhani A; Daar S; Al Haddabi H; Al Abri Q; Gravell D; Berbar T; Pravin S; Pathare A; Krishnamoorthy R
Hemoglobin; 2010 Jan; 34(2):135-44. PubMed ID: 20353348
[TBL] [Abstract][Full Text] [Related]
10. [S hemoglobinopathies in Argentina].
Abreu MS; Peñalver JA
Medicina (B Aires); 1992; 52(4):341-6. PubMed ID: 1340883
[TBL] [Abstract][Full Text] [Related]
11. Spectrum of hemoglobinopathies in the state of Orissa, India: a ten years cohort study.
Balgir RS
J Assoc Physicians India; 2005 Dec; 53():1021-6. PubMed ID: 16572956
[TBL] [Abstract][Full Text] [Related]
12. Pattern of haemoglobin phenotypes in newborn infants at the national hospital abuja using high performance liquid chromatography.
Mohammed-Nafi'u R; Audu LI; Ibrahim M; Wakama TT; Okon EJ
Niger Postgrad Med J; 2020; 27(3):190-195. PubMed ID: 32687118
[TBL] [Abstract][Full Text] [Related]
13. The Prevalence of Sickle Cell Disease and Its Implication for Newborn Screening in Germany (Hamburg Metropolitan Area).
Grosse R; Lukacs Z; Cobos PN; Oyen F; Ehmen C; Muntau B; Timmann C; Noack B
Pediatr Blood Cancer; 2016 Jan; 63(1):168-70. PubMed ID: 26275168
[TBL] [Abstract][Full Text] [Related]
14. Neonatal Screening for Sickle Cell Disease in Western Andalusia: Results and Lessons Learnt after 3 Years of Implementation.
Núñez-Jurado D; Payán-Pernía S; Álvarez-Ríos AI; Jiménez-Jambrina M; Concepcion Pérez-De-Soto I; José Palma-Vallellano A; Zapata-Bautista R; Carlos Hernández-Castellet J; Paz Garrastazul-Sánchez M; Arqueros-Martínez V; Urbano-Ramos MDM; Abdelkader-Maanan M; Raúl García-Lozano J; Delgado-Pecellín C
Am J Perinatol; 2024 May; 41(S 01):e893-e900. PubMed ID: 36580977
[TBL] [Abstract][Full Text] [Related]
15. Regional experience with newborn screening for sickle cell disease, other hemoglobinopathies and G6PD deficiency.
Nasserullah Z; Alshammari A; Abbas MA; Abu-Khamseen Y; Qadri M; Jafer SA; Wabel MA
Ann Saudi Med; 2003; 23(6):354-7. PubMed ID: 16868367
[TBL] [Abstract][Full Text] [Related]
16. [Hemoglobinopathies in Tunisia. An updated review of the epidemiologic and molecular data].
Fattoum S
Tunis Med; 2006 Nov; 84(11):687-96. PubMed ID: 17294892
[TBL] [Abstract][Full Text] [Related]
17. The Sub-Phenotypes of Sickle Cell Disease in Kuwait.
Adekile AD; Al-Sherida S; Marouf R; Mustafa N; Thomas D
Hemoglobin; 2019 Mar; 43(2):83-87. PubMed ID: 31144996
[TBL] [Abstract][Full Text] [Related]
18. [Neonatal screening for hemoglobinopathies: a one-year experience in the public health system in Rio Grande do Sul State, Brazil].
Sommer CK; Goldbeck AS; Wagner SC; Castro SM
Cad Saude Publica; 2006 Aug; 22(8):1709-14. PubMed ID: 16832542
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of sickle cell disease among Grenadian newborns.
Antoine M; Lee K; Donald T; Belfon Y; Drigo A; Polson S; Martin F; Mitchell G; Etienne-Julan M; Hardy-Dessources MD
J Med Screen; 2018 Mar; 25(1):49-50. PubMed ID: 29183229
[TBL] [Abstract][Full Text] [Related]
20. High Prevalence of Anemia and Inherited Hemoglobin Disorders in Tribal Populations of Madhya Pradesh State, India.
Chourasia S; Kumar R; Singh MPSS; Vishwakarma C; Gupta AK; Shanmugam R
Hemoglobin; 2020 Nov; 44(6):391-396. PubMed ID: 33222570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
